Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Placebo
34%
Randomized Controlled Trial
32%
Diseases
31%
Clinical Trial
24%
Disease Modifying Antirheumatic Drug
21%
Fibromyalgia
20%
Tumor Necrosis Factor
18%
Methotrexate
18%
Psoriatic Arthritis
14%
Adverse Event
14%
Glucocorticoid
13%
Interleukin 6
13%
Monoclonal Antibody
11%
Cardiovascular Disease
11%
Adalimumab
10%
Non-Steroidal Anti-Inflammatory Drug
9%
Inflammation
9%
Disease Activity
9%
Biological Product
8%
Disease Activity Score
8%
Duloxetine
7%
Interleukin 6 Receptor
7%
Sulfasalazine
6%
Etoricoxib
6%
Rheumatic Disease
6%
Ankylosing Spondylitis
6%
Syndrome
6%
Dermatomyositis
6%
Polymyositis
6%
Heart Infarction
6%
Immunosuppressive Agent
6%
Cytokine
6%
Tumor Necrosis Factor Inhibitor
5%
Morning Stiffness
5%
Arthritis
5%
Prednisolone
5%
Immunoglobulin G1
5%
Medicine and Dentistry
Rheumatoid Arthritis
53%
Inflammatory Arthritis
53%
Diseases
22%
Clinical Trial
18%
Fibromyalgia
16%
Randomized Controlled Trial
12%
Placebo
10%
Rheumatology
9%
Psoriatic Arthritis
8%
Methotrexate
7%
Quality of Life
7%
Glucocorticoid
7%
Duloxetine
6%
Health Assessment Questionnaire
6%
Dermatomyositis
6%
Polymyositis
6%
Cytokine
6%
Disease Modifying Antirheumatic Drug
6%
Immunosuppressant
5%
DAS28
5%
Nursing and Health Professions
Inflammatory Arthritis
54%
Rheumatoid Arthritis
54%
Fibromyalgia
13%
Rheumatic Disease
12%
Systematic Review
11%
Cardiovascular Disease
10%
Diseases
7%
Rheumatologist
7%
Glucocorticoid
7%
Tumor Necrosis Factor
6%
Self Care
6%
Osteoarthritis
6%
Quality Adjusted Life Year
5%
Disease Activity
5%
Health Assessment Questionnaire
5%
Methotrexate
5%
